SOBR News & Events

Sobr Safe files to sell 3.97M shares of common stock for holders

SOBR Safe announced that it has entered into definitive agreements for the issuance and sale of 1.29M shares of its common stock, Series C warrants to purchase up to an aggregate of 1.29M shares of common stock and Series D warrants to purchase up to an aggregate of 1.29M shares of common stock, at a purchase price of $1.55 per share and associated warrants in a private placement priced at-the-market under Nasdaq rules. The warrants will have an exercise price of $1.30 per share and will be exercisable immediately upon issuance. The Series C warrants will expire five years after the effective date of the resale registration statement and the Series D warrants will expire twenty-four months after the effective date of the resale registration statement. The aggregate gross proceeds to the company from the offering are expected to be approximately $2.0M, before deducting placement agent fees and other offering expenses. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.

Reports Q3 revenue $108.9M vs. $46.1M last year. "The third quarter marked another period of consistent operational progress and growing commercial traction," said SOBRsafe CEO David Gandini. "Since the launch of our SOBRsure TM GEN 2 device and reinvigorated brand platform late last year, we have seen steady month-over-month sales growth, with October representing our strongest sales month to date. Online sales remain a key contributor, supported by our newly enhanced e-commerce platform and more effective digital engagement strategy. We recently secured two new channel partners and continue to see expanding interest from organizations seeking discreet, reliable alcohol monitoring and detection solutions. Across both behavioral health and consumer markets, we are seeing increasing validation that our technology solutions and brand are resonating. Our marketing investments are driving measurable results, with website traffic up 266% and conversion rates improving as we refine our campaigns and segmentation. We have a clear end-of-year marketing plan that includes targeted messaging, influencer partnerships, and expanded social media activity designed to strengthen awareness heading into the critical holiday and "dry" January periods. The feedback from both consumers and behavioral health customers reinforces that our brand is gaining recognition and trust, and that our focused strategy is translating into sustained sales momentum."

SOBR Safe announced a significant technology milestone following comprehensive independent testing by KEA Technologies. The rigorous third-party evaluation assessed SOBRsafe's SOBRsure GEN 2 device across key technical parameters under controlled conditions, establishing the device as an alternative to monitor alcohol consumption in the behavioral health and wellness, and alcohol consumption and non-punitive management space. KEA Technologies conducted extensive evaluations covering critical performance areas including calibration linearity, environmental impacts, sensitivity and drift, and trace alcohol differentiation. The testing validated the SOBRsure GEN 2's core sensing capabilities and consistent performance across its expected environmental operating range. The device exhibited excellent calibration linearity, demonstrating performance even with low-level ethanol underscoring the strength of SOBRsafe's early detection technology. The device exhibited rapid ethanol response times of 30 seconds or less from initial exposure in controlled testing, including low-level, early detection scenarios. This rapid response capability, combined with the ability to differentiate trace alcohol concentrations in controlled conditions, highlights the underlying potential of SOBRsafe's monitoring and detection technology platform.